Axotrophin and leukaemia inhibitory factor (LIF) in transplantation tolerance

Por Metcalfe, Su M
Publicado em 2005

Increase of oleic acid in erythrocytes associated with malignancies

Por Metcalfe, Su, Newman, Hugh, Workman, Paul
Publicado em 1985

Neurodegenerative Disease: A Perspective On Cell-Based Therapy In The New Era Of Cell-Free Nano-Therapy

Por Metcalfe, Su M, Bickerton, Sean, Fahmy, Tarek
Publicado no Curr Pharm Des (2017)

Introduction: immunoregulation: harnessing T cell biology for therapeutic benefit

Por Metcalfe, Su M, Calne, Roy Y, Cobbold, Stephen P
Publicado em 2005

Multiple Sclerosis and the LIF/IL-6 Axis: Use of Nanotechnology to Harness the Tolerogenic and Reparative Properties of LIF

Por Metcalfe, Su M., Strom, Terry B., Williams, Anna, Fahmy, Tarek M.
Publicado no Nanobiomedicine (Rij) (2015)

P53 autoantibodies in 1006 patients followed up for breast cancer

Por Metcalfe, Su, Wheeler, Terence K, Picken, Sheila, Negus , Susanne, Jo Milner, A
Publicado em 2000

The E3 Ligase Axotrophin/MARCH-7: Protein Expression Profiling of Human Tissues Reveals Links to Adult Stem Cells

Por Szigyarto, Cristina A., Sibbons, Paul, Williams, Gill, Uhlen, Mathias, Metcalfe, Su M.
Publicado em 2010

Comparison of outcomes in patients with stage III versus limited stage IV non-small cell lung cancer

Por Chen Yuhchyau, Metcalfe Justin, Metcalfe Su K, Cheruvu Praveena, Okunieff Paul, Milano Michael T
Publicado em 2011-06-01

Mutational Biosynthesis of Novel Rapamycins by a Strain of Streptomyces hygroscopicus NRRL 5491 Disrupted in rapL, Encoding a Putative Lysine Cyclodeaminase

Por Khaw, Lake Ee, Böhm, Günter A., Metcalfe, Su, Staunton, James, Leadlay, Peter F.
Publicado em 1998

Comparison of outcomes in patients with stage III versus limited stage IV non-small cell lung cancer

Por Cheruvu, Praveena, Metcalfe, Su K, Metcalfe, Justin, Chen, Yuhchyau, Okunieff, Paul, Milano, Michael T
Publicado em 2011

Modulation of CD4+ T Lymphocyte Lineage Outcomes with Targeted, Nanoparticle-Mediated Cytokine Delivery

Por Park, Jason, Gao, Wenda, Whiston, Roy, Strom, Terry B., Metcalfe, Su, Fahmy, Tarek M.
Publicado em 2010

Myelin repair in vivo is increased by targeting oligodendrocyte precursor cells with nanoparticles encapsulating leukaemia inhibitory factor (LIF)

Por Rittchen, Sonja, Boyd, Amanda, Burns, Alasdair, Park, Jason, Fahmy, Tarek M., Metcalfe, Su, Williams, Anna
Publicado no Biomaterials (2015)

Treg versus Th17 lymphocyte lineages are cross-regulated by LIF versus IL-6

Por Gao, Wenda, Thompson, Lorraine, Zhou, Qiang, Putheti, Prabhakar, Fahmy, Tarek M., Strom, Terry B., Metcalfe, Su M.
Publicado em 2009

A LIF/Nanog axis is revealed in T lymphocytes that lack MARCH-7, a RINGv E3 ligase that regulates the LIF-receptor

Por Thompson, Lorraine H, Whiston, Roy A, Rakhimov, Yerzhan, Taccioli, Cristian, Liu, Chang-Gong, Croce, Carlo, Metcalfe, Su M
Publicado em 2010

Modelling of a targeted nanotherapeutic ‘stroma’ to deliver the cytokine LIF, or XAV939, a potent inhibitor of Wnt–β-catenin signalling, for use in human fetal dopaminergic grafts...

Por Zhao, Jing-Wei, Dyson, Sean C., Kriegel, Christina, Tyers, Pam, He, Xiaoling, Fahmy, Tarek M., Metcalfe, Su M., Barker, Roger A.
Publicado em 2014

Immuno-Isolation of Pancreatic Islet Allografts Using Pegylated Nanotherapy Leads to Long-Term Normoglycemia in Full MHC Mismatch Recipient Mice

Por Dong, Huansheng, Fahmy, Tarek M., Metcalfe, Su M., Morton, Steve L., Dong, Xiao, Inverardi, Luca, Adams, David B., Gao, Wenda, Wang, Hongjun
Publicado em 2012